Wayne H. Faber
Veticus President & Founder
I practiced Veterinary Medicine for 30 years and the need for complete microbial disinfection and tissue safety was never met. I always felt that chlorine was the antimicrobial of choice, but it was neither safe nor residual.
I became aware of a new chlorine technology in the form of hypochlorous acid (HOCl), chlorine’s safe and active ingredient, and was fortunate to discover a superior solution.
I am pleased to introduce Veticus HOCl. Our line of advanced formula 100% All–Natural skin care products are the purest, most stable and effective, topical solutions available in Veterinary Medicine today, as verified by highly reputable third-party laboratories and universities.
Our proprietary formula works to support the skin’s overall wellness in post-procedural care, irritations, sensitivities, and inflammation. Antibiotic resistance is a non-issue with our pure HOCl, and it presents no side effects or contraindications. It is safe, non-irritating, hypo-allergenic, and economical. This is truly one of the major contributions to the science of Veterinary Medicine for 2017.
I started Veticus to fill the need for application of this superior technology and invite you to make our stable of HOCl products with this unique attribute part of your treatment plans. Discover yourself how using the most advanced HOCl products will lead to the best patient outcomes. To learn more about the science behind HOCl click here.
Wayne H. Faber, DVM
ISU Vet Med, '54
It is our mission to make the most effective skin care solutions readily available so that companion animals and livestock can be healthier and live more comfortably.
As the science underlying the issues of viral, bacterial, and fungal contamination advances, our goal at Veticus is to be the leader in bringing these breakthrough advancements to the veterinary profession.
Veticus HOCl is the purest, most stable and effective, and all-natural skin care solution available in Veterinary Medicine today. Veticus addresses every stage of your patients' therapy.